These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7591020)

  • 1. Enhanced levels of tissue-type plasminogen activator in borderline hypertension.
    Wall U; Jern C; Bergbrant A; Jern S
    Hypertension; 1995 Nov; 26(5):796-800. PubMed ID: 7591020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension.
    Jern S; Wall U; Bergbrant A; Selin-Sjögren L; Jern C
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3376-83. PubMed ID: 9437182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic system in normotensive subjects and hypertensive patients.
    Armas-Hernández MJ; Hernández-Hernández R; Armas-Padilla MC; Sosa-Canache B; Cammarata R; Pacheco B; Guerrero-Pajuelo J; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):177-82. PubMed ID: 17414587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden.
    Eliasson M; Jansson JH; Nilsson P; Asplund K
    J Hypertens; 1997 Apr; 15(4):349-56. PubMed ID: 9211169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
    Erdem Y; Usalan C; Haznedaroğlu IC; Altun B; Arici M; Yasavul U; Turgan C; Cağlar S
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1071-6. PubMed ID: 10604482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function and fibrinolytic activity during rest and exercise in borderline hypertensive patients.
    Gleerup G; Vind J; Winther K
    Eur J Clin Invest; 1995 Apr; 25(4):266-70. PubMed ID: 7601202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fibrinolytic system is not impaired in older men with hypertension.
    DeSouza CA; Dengel DR; Rogers MA; Cox K; Macko RF
    Hypertension; 1996 May; 27(5):1053-8. PubMed ID: 8621196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension.
    Preston RA; Coffey JO; Materson BJ; Ledford M; Alonso AB
    Atherosclerosis; 2007 May; 192(1):148-54. PubMed ID: 16764881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.
    Huber K; Beckmann R; Frank H; Kneussl M; Mlczoch J; Binder BR
    Am J Respir Crit Care Med; 1994 Oct; 150(4):929-33. PubMed ID: 7921465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.
    Gray RP; Patterson DL; Yudkin JS
    Arterioscler Thromb; 1993 Mar; 13(3):415-20. PubMed ID: 8443145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets.
    Simpson AJ; Gray RS; Moore NR; Booth NA
    Br J Haematol; 1997 Apr; 97(1):208-13. PubMed ID: 9136967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
    Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
    Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of blood pressure with fibrinolytic potential in the Framingham offspring population.
    Poli KA; Tofler GH; Larson MG; Evans JC; Sutherland PA; Lipinska I; Mittleman MA; Muller JE; D'Agostino RB; Wilson PW; Levy D
    Circulation; 2000 Jan; 101(3):264-9. PubMed ID: 10645922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.